Featured Expert: Walter Bouwmeester
This month, PRECISIONheor highlights Director, Walter Bouwmeester.
Insights90: Marlon Graf
In these past few years, life has been filled with uncertainty. Listen as Precision’s Marlon Graf discusses how PRECISIONheor finds ways to deal with uncertainty in healthcare decision making in this Insights90.
Equity in Clinical Research: From Trials to Treatment
Many pharmaceutical and medical device companies have made commitments to address health inequities as they exist in the realm of clinical trials. Precision's Alice Pressman co-authors this article discussing some of the obstacles, solutions, and implications for widespread efforts to improve health equity throughout the clinical research cycle. Learn More: https://lnkd.in/gxZKf_C2https://lnkd.in/gxZKf_C2
Miss any of our Recent Precision Value & Health Events? Check out our June Events Calendar
Miss any of our recent Precision Value & Health events? Check out our monthly marketing activities calendar to catch up on-demand, and stay ahead of upcoming dates!
Cost-Effectiveness Analysis With R?
This white paper summarizes a recent webinar convened by PRECISIONheor, moderated by Dr. Jeroen Jansen, Chief Scientist. The webinar featured a discussion surrounding the use of R for model-based cost-effectiveness analysis, and what can be done to increase its uptake and acceptance.
Insights90: Jacki Chou
Following up from her last Insights90, Jacki Chou returns to explain 3 major changes in ICER’s recently released protocol for the 2022 national unsupported price increase assessment.
Featured Expert: Andrea Berardi
This month, PRECISIONheor highlights Director, Health Economics, Andrea Berardi.
Big Data Analytics in Health Care and Drug Therapy Management—Opportunities and Considerations
Modern technology allows for the mass collection of digital health data. Artificial intelligence has become a vital tool for making sense of the huge volume of health data being collected daily through the use of big data analytics (BDA).
Insights90: Meaghan Roach
Last month, the FDA Office of Prescription Drug Promotion announced they will be conducting a discrete choice experiment study to understand how both patients and physicians weigh attributes of potential treatments.
ISPOR 2022
Did you see our workshops and poster presentations at this year's ISPOR conference in Washington, DC?
